SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
NYSE New York Stock Exchange
Börse NYSE New York Stock Exchange
ISIN US1598641074
USD
  • Charles River Laboratories
    Börse NYSE New York Stock Exchange
    ISIN US1598641074 WKN: 939391
    Symbol CRL
    USD
  • CHARLES RIVER LABORATORIES
    Börse Gettex System der Börse München
    Symbol RV6
    EUR
  • CHARLES RIVER LABORATORIES
    Börse Börse Düsseldorf
    Symbol RV6
    EUR
  • CHARLES RIVER LABORATORIES
    Börse Börse München
    Symbol RV6
    EUR
  • CHARLES RIVER LABORATORIES
    Börse Tradegate System der Deutsche Börse AG (60%)
    Symbol RV6
    EUR
  • CHARLES RIVER LABORATORIES
    Börse Börse Frankfurt
    Symbol RV6
    EUR
  • CHARLES RIVER LABORATORIES
    Börse Börse Berlin
    Symbol RV6
    EUR
  • CHARLES RIVER LABORATORIES
    Börse Quotrix System der Börse Düsseldorf
    Symbol RV6
    EUR
  • ISIN US1598641074
    Symbol RV6
  • Symbol RV6
ISIN US1598641074
WKN 939391
Symbol CRL
Währung USD
Börse NYSE New York Stock Exchange Zeitzone: Europe/Berlin
Marktkapitalisierung 15.430.645.216 (+- 6%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

14.534.290.432 oder 16.327.000.000

Mitarbeiter 17.850 (+- 4%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

17.100 oder 18.600 Mitarbeiter

KGV 40.58
EBITDA 667.652.992
PEGRatio 2.0415
Buchwert 42.49

Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 282 EUR +0,71% 

30 News & Informationen zur Charles River Laboratories Aktie

  • Charles River Laboratories International, Inc. (CRL) CEO Jim Foster on Q2 2021 Results - Earnings Call Transcript
    seekingalpha.com

    Charles River Laboratories International, Inc. (CRL) CEO Jim Foster on Q2 2021 Results – Earnings Call Transcript

    Charles River Laboratories International, Inc. (NYSE:CRL) Q2 2021 Earnings Conference Call August 4, 2021 9:30 AM ET Company Participants Todd Spencer – Corporate Vice President, Investor…

  • Charles River Laboratories International, inc (CRL) Q2 2021 Earnings Call Transcript
    fool.com

    Charles River Laboratories International, inc (CRL) Q2 2021 Earnings Call Transcript

    CRL earnings call for the period ending June 30, 2021.

  • Global Drug Discovery Outsourcing Market In Pharmaceuticals Industry|Discover Company Insights In Technavio
    thestreet.com

    Global Drug Discovery Outsourcing Market In Pharmaceuticals Industry|Discover Company Insights In Technavio

    NEW YORK, July 23, 2021 /PRNewswire/ — The drug discovery outsourcing market is poised to grow by USD 1.42 billion during 2021-2025, progressing at a CAGR of

  • First Quadrant L P Buys Alliant Energy Corp, Roku Inc, Cara Therapeutics Inc, Sells iShares iBoxx USD High Yield Corporate Bond ETF,...
    gurufocus.com

    First Quadrant L P Buys Alliant Energy Corp, Roku Inc, Cara Therapeutics Inc, Sells iShares iBoxx USD High Yield Corporate Bond ETF, UnitedHealth Group Inc, Visa Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Jag Capital Management, Llc Buys Facebook Inc, Generac Holdings Inc, RH, Sells Insulet Corp, Chipotle Mexican Grill Inc, Cintas Corp
    gurufocus.com

    Jag Capital Management, Llc Buys Facebook Inc, Generac Holdings Inc, RH, Sells Insulet Corp, Chipotle Mexican Grill Inc, Cintas Corp

    GuruFocus Article or News written by insider and the topic is about:

  • Charles River Laboratories International Inc (CRL): Price Now Near $395.43; Daily Chart Shows An Uptrend on 50 Day Basis
    etfdailynews.com

    Charles River Laboratories International Inc (CRL): Price Now Near $395.43; Daily Chart Shows An Uptrend on 50 Day Basis

  • Sitrin Capital Management LLC Buys Carnival Corp, Apple Inc, Airbnb Inc, Sells Chewy Inc, Kimberly-Clark Corp, DraftKings Inc
    gurufocus.com

    Sitrin Capital Management LLC Buys Carnival Corp, Apple Inc, Airbnb Inc, Sells Chewy Inc, Kimberly-Clark Corp, DraftKings Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Global pharmaceutical contract manufacturing market size to record 7.5% CAGR through 2027
    globenewswire.com

    Global pharmaceutical contract manufacturing market size to record 7.5% CAGR through 2027

    The latest business intelligence report on ‘global pharmaceutical contract manufacturing market’ offers an accurate picture of the industry’s growth…

  • Chevy Chase Trust Holdings, Inc. Buys Franco-Nevada Corp, ChampionX Corp, Nasdaq Inc, Sells iShares Gold Trust, Splunk Inc, Seagate...
    gurufocus.com

    Chevy Chase Trust Holdings, Inc. Buys Franco-Nevada Corp, ChampionX Corp, Nasdaq Inc, Sells iShares Gold Trust, Splunk Inc, Seagate Technology Holdings PLC

    GuruFocus Article or News written by insider and the topic is about:

  • Hedge Funds Have Never Been This Bullish On News Corp (NWS)
    insidermonkey.com

    Hedge Funds Have Never Been This Bullish On News Corp (NWS)

    How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However…

  • IFM Investors Pty Ltd Buys Apple Inc, Microsoft Corp, Amazon.com Inc, Sells Alphabet Inc, IHS Markit,
    gurufocus.com

    IFM Investors Pty Ltd Buys Apple Inc, Microsoft Corp, Amazon.com Inc, Sells Alphabet Inc, IHS Markit,

    GuruFocus Article or News written by insider and the topic is about:

  • Global Animal Model Market Is Expected to Reach $2.67 Billion by 2030: Says AMR
    globenewswire.com

    Global Animal Model Market Is Expected to Reach $2.67 Billion by 2030: Says AMR

    Increase in usage of animal models in virology and infectious diseases, rise in adoption of CRISPR technology, and upsurge in likelihood of epidemic or…

  • Charles River Laboratories International : Schedules Second-Quarter 2021 Earnings Release and Conference Call
    marketscreener.com

    Charles River Laboratories International : Schedules Second-Quarter 2021 Earnings Release and Conference Call

    Charles River Laboratories International, Inc. will release second-quarter 2021 financial results on Wednesday, August 4th, before the market opens. A conference call has been scheduled to discuss… | July 13, 2021

  • Medical Device Outsourced Manufacturing Market to Grow at a CAGR of 14.6% from 2021 to 2030
    globenewswire.com

    Medical Device Outsourced Manufacturing Market to Grow at a CAGR of 14.6% from 2021 to 2030

    The global medical device outsourced manufacturing market has been estimated to reach USD 43.2 million in 2021 and is projected to grow at a CAGR of 14.6%…

  • Medical Device Outsourced Manufacturing Market to Grow at a CAGR of 14.6% from 2021 to 2030
    globenewswire.com

    Medical Device Outsourced Manufacturing Market to Grow at a CAGR of 14.6% from 2021 to 2030

    The global medical device outsourced manufacturing market has been estimated to reach USD 43.2 million in 2021 and is projected to grow at a CAGR of 14.6%…

  • Rapid Microbiology Testing Market worth $6.7 billion by 2026 - Exclusive Report by MarketsandMarkets™
    prnewswire.com

    Rapid Microbiology Testing Market worth $6.7 billion by 2026 – Exclusive Report by MarketsandMarkets™

    /PRNewswire/ — According to the new market research report “Rapid Microbiology Testing Market by Product (Reagents, Kits, Automated Identification System,…

  • Do Hedge Funds Love Lumen Technologies, Inc. (LUMN)?
    insidermonkey.com

    Do Hedge Funds Love Lumen Technologies, Inc. (LUMN)?

    We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on…

  • Global Genetic Toxicology Testing Market is Estimated to Grow at a CAGR of 10.0% from 2021 to 2030
    globenewswire.com

    Global Genetic Toxicology Testing Market is Estimated to Grow at a CAGR of 10.0% from 2021 to 2030

    Browse key industry insights spread across 155 pages with 85 market data tables and 41 figures & charts from the report, “Global Genetic Toxicology Testing…

  • Global Genetic Toxicology Testing Market is Estimated to Grow at a CAGR of 10.0% from 2021 to 2030
    globenewswire.com

    Global Genetic Toxicology Testing Market is Estimated to Grow at a CAGR of 10.0% from 2021 to 2030

    Browse key industry insights spread across 155 pages with 85 market data tables and 41 figures & charts from the report, “Global Genetic Toxicology Testing…

  • Global In Vitro Toxicology Testing Market is Estimated to Grow at a CAGR of 11.2% from 2021 to 2030
    globenewswire.com

    Global In Vitro Toxicology Testing Market is Estimated to Grow at a CAGR of 11.2% from 2021 to 2030

    In Vitro Toxicology Testing Market, by Product and Service (Consumables, Assays, Equipment, Software, and Services), Methods (Cellular Assays, Biochemical…

  • Global In Vitro Toxicology Testing Market is Estimated to Grow at a CAGR of 11.2% from 2021 to 2030
    globenewswire.com

    Global In Vitro Toxicology Testing Market is Estimated to Grow at a CAGR of 11.2% from 2021 to 2030

    In Vitro Toxicology Testing Market, by Product and Service (Consumables, Assays, Equipment, Software, and Services), Methods (Cellular Assays, Biochemical…

  • Worldwide Clinical Laboratory Services Industry To 2026 - By Type Service Provider And Region
    thestreet.com

    Worldwide Clinical Laboratory Services Industry To 2026 – By Type Service Provider And Region

    DUBLIN, July 2, 2021 /PRNewswire/ — The

  • Worldwide Clinical Laboratory Services Industry to 2026 - by Type Service Provider and Region
    prnewswire.com

    Worldwide Clinical Laboratory Services Industry to 2026 – by Type Service Provider and Region

    /PRNewswire/ — The

  • Laboratory Animals And Supplies Market to reach USD 6.08 Billion by 2024 | SpendEdge
    prnewswire.com

    Laboratory Animals And Supplies Market to reach USD 6.08 Billion by 2024 | SpendEdge

    /PRNewswire/ — SpendEdge has been monitoring the Laboratory Animals And Supplies Market and it is poised to grow by USD 6.08 Billion by 2024. The report…

  • Charles River Laboratories International : Completes Acquisition of Vigene Biosciences
    marketscreener.com

    Charles River Laboratories International : Completes Acquisition of Vigene Biosciences

    Charles River Laboratories International, Inc. announced today that it has completed the previously announced acquisition of Vigene Biosciences, Inc. for $292.5 million in cash, subject to customary… | June 29, 2021

  • Charles River Laboratories Completes Acquisition of Vigene Biosciences
    finanzen.net

    Charles River Laboratories Completes Acquisition of Vigene Biosciences

    Charles River Laboratories Completes Acquisition of Vigene Biosciences | Nachricht | finanzen.net

  • Hedge Funds Have Never Been This Bullish On Cognex Corporation (CGNX)
    insidermonkey.com

    Hedge Funds Have Never Been This Bullish On Cognex Corporation (CGNX)

    Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed…

  • Global Contract Research Outsourcing Market To Reach $67.1 Billion By 2026
    thestreet.com

    Global Contract Research Outsourcing Market To Reach $67.1 Billion By 2026

    SAN FRANCISCO, June 25, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today

  • Here is What Hedge Funds Think About Charles River Laboratories International Inc. (CRL)
    insidermonkey.com

    Here is What Hedge Funds Think About Charles River Laboratories International Inc. (CRL)

    While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending,…

  • CombiGene : GMP plasmids released – Ready to start GMP production of CG01
    marketscreener.com

    CombiGene : GMP plasmids released – Ready to start GMP production of CG01

    Cobra Biologics , the gene therapy division of Cognate BioServices, a Charles River Laboratories International, Inc. company and CombiGene AB , the leading gene therapy company in the… | June 23, 2021

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Charles River Laboratories Aktie

Das Unternehmen Charles River Laboratories International, Inc aus USA beschäftigt 17.850 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie tätig.

Das Unternehmen Charles River Laboratories International, Inc ist in mehr als 42 ETFs enthalten und somit eine vermutlich durchschnittlich bekannte Aktie. Der Spitzenreiter VanEck Vectors Biotech ETF gewichtet Charles River Laboratories mit 5,15% im ETF.

Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Charles River Laboratories Anleihen auf einen Blick.

Entdecke die 6 ETFs in denen Charles River Laboratories International, Inc am höchsten gewichtet ist Insgesamt in 42 ETFs enthalten

Dir gefallen die Informationen zu Charles River Laboratories?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Charles River Laboratories?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Charles River Laboratories?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Charles River Laboratories?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic